“…… Don't worry, this kind of thing is not in a hurry. ”

In the temporary R&D center of Heinz Pharmaceuticals, John patiently comforted Mr. Hoffman, the head of R&D who was full of frustration, and at the same time cheered him up with realistic support: "The company will continue to guarantee annual R&D funds, so that you can continue to research...... I always believe that hard work pays off! ”

"Thank you, Mr. Huntelaar."

After listening to John's words, Mr. Hoffman finally regained a little confidence.

In fact, it is no wonder that the R&D director of Heinz Pharmaceutical Company has hit them too hard this year. John alone was able to discover three sulfonamide drugs, but after the establishment of the R&D department of Heinz Pharmaceuticals, dozens of people worked hard for a year to find only five, and it turned out that they were not suitable for the treatment of diseases.

Not to mention the pressure that Ehrlich put on him in another part of the company.

Although Ehrlich was nominally under Hoffmann's control, it was clear to almost everyone in the company that the young man, who seemed to be better than the head of R&D, was directly under Mr. Huntelaar. While the company's R&D staff focused on sulfonamides and tried to find more derivatives, only Ehrlich remained independent of all R&D personnel, concentrating on what others thought was pointless, such as studying the drug effects of the three sulfonamide products.

All Mr. Ehrlich can come up with is one paper after another......

"Gotcha! Get! ”

Just as John was about to appease Hoffman a little more, there was a knock on the door of the head of R&D, and Mr. Nicklaus, the general manager of Heinz Pharmaceuticals, walked in.

"Sir, do you really want to go back to the United States?"

As soon as he entered the door, Nicklaus asked in a solemn and urgent voice, "Can't it be postponed for a while?" The company is now growing very rapidly. But ......"

"Mr. Nicklaus, sit down first."

Before the other party could finish speaking, John had already waved his hand to interrupt Mr. Manager's words.

Of course, he knew what Nicklaus had not said, because John knew very well that Heinz Pharmaceuticals, despite its strong momentum, had been selling steadily at around two million marks in recent months. But as several new drugs have been on the market for more than or nearly a year, various problems have surfaced. For example, the problem of allergies and adverse reactions to sulfonamides, for example, the problem of how to prepare aspirin, which has just been discovered by the French, and for example, the sporadic fatal cases of two local anesthetics......

At this time, John's departure from Europe really did not seem very appropriate.

Although the majority shareholder and de facto owner of Heinz Pharmaceuticals rarely comes to the company, especially when several new drugs are slowly on the right track, both Nicklaus and Hoffman, including Ehrlich, who is immersed in research, actually see him as the core of the company. Because he is the inventor of all new medicines. At the same time, he is also the name of aspirin and the pioneer of new marketing methods, so although most of the people who usually come to the company are old Huntelaar, but in the hearts of everyone, Mr. Huntelaar Jr. is the real backbone.

So when they heard the news that John was leaving, both Nicklaus and Hoffman were a little anxious.

Under the staring gaze of the two of them, John paused slightly and said with a smile: "Gentlemen, it is undeniable that the company is experiencing some difficulties now, but I personally think that these things are completely controllable. Otherwise, I'm afraid the sales of our products would have dropped a long time ago, wouldn't they? ”

"Uh......"

Nicklaus and Hoffman looked at each other. Silent with each other.

Smiling again, John continued: "It is normal for sulfonamides and local anesthetics to have some accidents, how can there be drugs on the market that are completely effective and not dangerous?" What we need to do is not to panic because of this, but to continue to study them, and cooperate with the doctors at Charlotte Hospital to conduct detailed analysis and accurate judgment, and give warnings or suggestions to the doctors...... I believe so. The benefits of these drugs must outweigh the harms, don't they? ”

John already knew the adverse effects of these drugs. It's just that for him now, there is no way to solve these problems, and of course, it is impossible to give up food due to choking. As a result, several drugs were taken off the shelves. At least for this day and age, there is no doubt that sulfonamides and local anesthetics are still the best drugs in the world, despite all these shortcomings.

"Yes, sir."

This time, Nicklaus nodded without hesitation.

Compared to John and Hoffman, Nicklaus, as general manager, is more aware of the sources of some of the doubts and why these people have begun to attack Heinz Pharmaceutical's drugs......

The current Heinz pharmaceutical company is too strong.

In just over a year, Heinz Pharmaceutical's monthly sales exceeded two million marks, and this figure has stabilized. This is still because of the bottleneck in the marketing power of Heinz Pharmaceutical Company in a short period of time, and it is conceivable that with the expansion of the influence of the company and several drugs, this number will inevitably continue to rise, thus bringing more huge profits to Heinz Pharmaceutical!

And it is this huge profit that attracts many jealous and pretenders.

Hoffman and Nicklaus may have been worried, but John didn't pay much attention to it. Although there are many frustrating things in this era compared to later generations, in Europe, everyone basically follows certain rules of the game. John is absolutely "original" and has too many drugs that are ahead of his time in terms of technology, and he is not afraid of other competitors at all, and it will be difficult for other companies to develop and produce them on a large scale like Heinz Pharmaceutical Company for at least ten years.

The only thing that makes people scratch their heads is aspirin.

Aspirin is derived from salicylic acid, which has been used by Europeans for a long time, and its ingredient acetylsalicylic acid has been synthesized for decades. So from the very beginning, John didn't have much hope when he asked people to apply for a patent, because he knew a lot of truth about the Aspirin Wars in later generations. So when he heard that the French had discovered what the active ingredient of aspirin was, and had found another way to prepare it, there were not many surprises at all.

So after thinking about it, John then smiled and said: "As for aspirin, I think if the French want to compete with us, let him go, I believe that our preparation technology should be the best, they can't do it at a lower cost than us, and ...... Many doctors in Europe are now accustomed to the name aspirin, aren't they? ”

"This ......"

Looking at John, who had an indifferent face, Nicklaus couldn't help but feel a strange feeling in his heart.

When he named the new drug aspirin, to be honest, he was still a little unimpressed, but now he has completely understood John's tricks. Physicians who have used this drug have become accustomed to the name aspirin, and they will habitually write it down when prescribing it, so even if the French clearly tell them that the ingredient of aspirin is acetylsalicylic acid, the power of habit is still unbreakable.

In true history, Bayer has relied on this method to defeat its enemies.

"And ......"

John raised his eyebrows, and then smiled: "Now that hundreds of papers have appeared in academic journals all over Europe and even in North America, all of which use the name aspirin, what are you worried about?" If it really doesn't work, they will lower the price and compete with the French...... I don't think I need to teach you these methods, do I? ”

"No, no."

After swallowing hard, Nicklaus nodded vigorously. As a seasoned business veteran, if this is something that John needs to teach, then he might as well bang his head against the wall of this office......

……

Coming out of Hoffman's office, John finally breathed a sigh of relief.

As for the development of Heinz Pharmaceutical Company in the next year or two, he has already made plans for it - he does not expect them to open up, as long as he can stabilize the current situation. In fact, John also had a feeling that the development of Heinz Pharmaceutical Company was too fast, especially in 1886, when the six drugs were ahead of their time, and almost all European physicians were shaken. Fortunately, the current level of physicians and communication is still low, and local protectionism is prevalent, so the growth rate of Heinz Pharmaceutical's sales slowed down immediately after reaching 2 million marks......

Even so, Heinz now has more than 1,000 employees and annual sales of more than 20 million marks, which is already a behemoth!

Such a scale made John a little uneasy.

Therefore, in addition to investing heavily in the construction of R&D centers, and began to plan more land and more advanced plants and equipment, John invested a lot of the profits of pharmaceutical companies in R&D teams. All of them are centered on thoroughly consolidating the foundation of Heinz Pharmaceuticals. So Hoffman they have no results, John doesn't care, how much dividends he can get throughout the year, John doesn't care, he doesn't care if the company can occupy more markets in the next year or two, he doesn't care......

Coming out of Hoffman's office, John made a beeline for Ehrlich's office in another building.

After knocking on the door, John saw Ehrlich, who was already waiting for him. The future academic expert immediately stood up from his seat and greeted him with a smile on his face: "Mr. Huntelaar, I have already considered it, and I would like to work with you in North America for a long time......"

……

This was last night, sorry for being late.

Volume 6 has two or three more chapters than expected, so let's end tonight. (To be continued......)